Search Results - "Van Kampen, R. J. W."

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? by Lobbezoo, D J A, van Kampen, R J W, Voogd, A C, Dercksen, M W, van den Berkmortel, F, Smilde, T J, van de Wouw, A J, Peters, F P J, van Riel, J M G H, Peters, N A J B, de Boer, M, Peer, P G M, Tjan-Heijnen, V C G

“…Background: We aimed to determine the prognostic impact of time between primary breast cancer and diagnosis of distant metastasis (metastatic-free interval,…”
Get full text

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium by Lobbezoo, D.J.A., van Kampen, R.J.W., Voogd, A.C., Dercksen, M.W., van den Berkmortel, F., Smilde, T.J., van de Wouw, A.J., Peters, F.P.J., van Riel, J.M.G.H., Peters, N.A.J.B., de Boer, M., Peer, P.G.M., Tjan-Heijnen, V.C.G.

“…The objective of this study was to present initial systemic treatment choices and the outcome of hormone receptor-positive (HR+) metastatic breast cancer. All…”
Get full text

Thorium dioxide-related haemangiosarcoma of the liver by VAN KAMPEN, R. J. W, ERDKAMP, F. L. G, PETERS, F. P. J

“…Rare tumours of the liver are occasionally seen; thorium dioxide-related haemangiosarcoma of the liver, with an estimated frequency of 0.14 to 0.25 per million…”
Get full text

Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium by van Kampen, R.J.W, Ramaekers, B.L.T, Lobbezoo, D.J.A, de Boer, M, Dercksen, M.W, van den Berkmortel, F, Smilde, T.J, van de Wouw, A.J, Peters, F.P.J, van Riel, J.M.G, Peters, N.A.J.B, Tjan-Heijnen, V.C.G, Joore, M.A

“…Abstract Introduction The aim of our analysis was to assess the real-world cost-effectiveness of bevacizumab in addition to taxane treatment versus taxane…”
Get full text

Initiating and potentiating role of platelets in tissue factor‐induced thrombin generation in the presence of plasma: subject‐dependent variation in thrombogram characteristics by Vanschoonbeek, K., Feijge, M. A. H., Van Kampen, R. J. W., Kenis, H., Hemker, H. C., Giesen, P. L. A., Heemskerk, J. W. M.

“…The hemostatic activity of plasma is determined by platelet activation and coagulation, which processes are mutually stimulatory. We studied this interaction…”
Get full text

Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial by Seefat, M.R., Stege, C.A.M., Lissenberg-Witte, B.I., Levin, M.D., Timmers, G.J., Hoogendoorn, M., Ypma, P.F., Klein, S.K., Velders, G.A., Westerman, M., Strobbe, L., Durdu-Rayman, N., Davidis-van Schoonhoven, M.A., van Kampen, R.J.W., Dijk, A.C., Koster, A., Silbermann, M.H., van der Spek, E., Beeker, A., Erjavec, Z., de Graauw, N.C.H.P., Leys, M.B.L., Sonneveld, P., van de Donk, N.W.C.J., Nasserinejad, K., Blommestein, H.M., Cucchi, D.G.J., Zweegman, S.

“…Frailty in newly-diagnosed multiple myeloma (NDMM) patients is associated with treatment-related toxicity, which negatively affects health-related quality of…”
Get full text

Serious intoxication after inhaling methanol by van Kampen, R J W, Krekels, M M E, Derijks, H J, Peters, F P J

“…A 38-year-old man presented with severe methanol intoxication after inhaling methanol over a period of 36 hours in a poorly-ventilated laboratory. He…”
Get more information